Moffitt Notice of Blackbaud Data Incident. Learn More
Who Is Most at Risk for Developing Brain Cancer?
There are several traits that have been identified as making a person more likely to develop brain cancer. However, having one or more risk factors for brain cancer does not necessarily mean a person will develop this malignancy. Likewise, it is possible for an individual to develop brain cancer despite having no known risk factors. Still, it is especially important for those who have risk factors for brain cancer to be aware of the symptoms of this malignancy, closely monitor their health and promptly report any abnormalities to their physician.
Genetic risk factors for brain cancer
There are several genetic conditions that individuals can inherit that may put them at a higher risk for developing brain cancer. These conditions include:
- Tuberous sclerosis
- Von Hippel-Lindau disease
- Neurofibromatosis type 1 and 2
- Li-Fraumeni syndrome
Other risk factors for brain cancer
There are several non-genetic risk factors for brain cancer, as well. These can include:
- Receiving prior radiation therapy to the head or neck
- Having immune system disorders (such as AIDS)
- Being infected with the Epstein-Barr virus (this can increase the likelihood of developing lymphoma of the central nervous system)
- Being an older adult
- Being male
Where to go for risk assessment and treatment
Those who are concerned with their brain cancer risk factors are encouraged to schedule a consultation at Moffitt Cancer Center. As a high-volume cancer center, Moffitt treats a large number of patients with brain cancer each year, meaning our experts have a great deal of experience diagnosing and treating this malignancy. Our multispecialty team can help you determine the appropriate steps you should take to remain vigilant about your health. In the event that brain cancer is found, we will develop an individualized, comprehensive treatment plan that will give you the best chance at achieving a favorable outcome and an improved quality of life.